95 related articles for article (PubMed ID: 18485151)
1. Dispensing of anxiolytics and hypnotics in southeastern France: demographic factors and determinants of geographic variations.
Bocquier A; Bezzou K; Nauleau S; Verger P
Fundam Clin Pharmacol; 2008 Jun; 22(3):323-33. PubMed ID: 18485151
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world].
Pélissolo A; Boyer P; Lépine JP; Bisserbe JC
Encephale; 1996; 22(3):187-96. PubMed ID: 8767047
[TBL] [Abstract][Full Text] [Related]
4. Use of benzodiazepines, hypnotics, and anxiolytics in major depressive disorder: association with chronic pain diseases.
Liu X; Ye W; Watson P; Tepper P
J Nerv Ment Dis; 2010 Aug; 198(8):544-50. PubMed ID: 20699718
[TBL] [Abstract][Full Text] [Related]
5. [Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study].
Gasquet I; Nègre-Pagès L; Fourrier A; Nachbaur G; El-Hasnaoui A; Kovess V; Lépine JP
Encephale; 2005; 31(2):195-206. PubMed ID: 15959446
[TBL] [Abstract][Full Text] [Related]
6. [Impact of the estimation of the medically insured population on the pharmacological prevalence of diabetes at the regional and small area level].
Jardin M; Bocquier A; Nauleau S; Millon C; Verger P
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):159-67. PubMed ID: 19403251
[TBL] [Abstract][Full Text] [Related]
7. Factors in duration of anxiolytic, sedative, and hypnotic drug use in the elderly.
Voyer P; McCubbin M; Préville M; Boyer R
Can J Nurs Res; 2003 Dec; 35(4):126-49. PubMed ID: 14746125
[TBL] [Abstract][Full Text] [Related]
8. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
[TBL] [Abstract][Full Text] [Related]
9. Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study.
Fang SY; Chen CY; Chang IS; Wu EC; Chang CM; Lin KM
Drug Alcohol Depend; 2009 Sep; 104(1-2):140-6. PubMed ID: 19515515
[TBL] [Abstract][Full Text] [Related]
10. Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice: a cross-sectional study based on French and Italian prescribing data.
Darmon D; Laforest L; Van Ganse E; Petrazzuoli F; van Weel C; Letrilliart L
BMC Fam Pract; 2015 Feb; 16():14. PubMed ID: 25655671
[TBL] [Abstract][Full Text] [Related]
11. The community prevalence of depression in older Australians.
Pirkis J; Pfaff J; Williamson M; Tyson O; Stocks N; Goldney R; Draper B; Snowdon J; Lautenschlager N; Almeida OP
J Affect Disord; 2009 May; 115(1-2):54-61. PubMed ID: 18817976
[TBL] [Abstract][Full Text] [Related]
12. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands.
van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
Aliment Pharmacol Ther; 2009 Mar; 29(5):571-9. PubMed ID: 19035978
[TBL] [Abstract][Full Text] [Related]
13. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
Grolleau A; Cougnard A; Bégaud B; Verdoux H
Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
[TBL] [Abstract][Full Text] [Related]
14. Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study.
Bénard-Laribière A; Noize P; Pambrun E; Bazin F; Verdoux H; Tournier M; Bégaud B; Pariente A
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):162-169. PubMed ID: 27807907
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and social determinants of anxiolytics and hypnotics use in women in Poland: a population-based study.
Zagozdzon P; Kolarzyk E; Marcinkowski JT
Int J Soc Psychiatry; 2013 May; 59(3):296-300. PubMed ID: 22491757
[TBL] [Abstract][Full Text] [Related]
16. [Duty militaries' consumption of psychotropic drugs in 2005].
Desjeux G; Aspar AM; Colonna-d'Istria E; Raude D; Birioukoff M; Balaire C; Codaccioni A; Thevenin-Garron V
Encephale; 2009 Jun; 35(3):249-55. PubMed ID: 19540411
[TBL] [Abstract][Full Text] [Related]
17. Analysis of regional differences in the amount of hypnotic and anxiolytic prescriptions in Japan using nationwide claims data.
Okui T; Park J
BMC Psychiatry; 2022 Jan; 22(1):44. PubMed ID: 35045851
[TBL] [Abstract][Full Text] [Related]
18. [Mortality of psychiatric inpatients in France during World War II: a demographic study].
Chapireau F
Encephale; 2009 Apr; 35(2):121-8. PubMed ID: 19393380
[TBL] [Abstract][Full Text] [Related]
19. Dispensing Patterns of Anxiolytics and Sedative-Hypnotics: A Feasibility Study Comparing Datasets from a Developed and a Developing Country (Australia and South Africa).
Kairuz T; Truter I; Rossato L; Pudmenzky A
Curr Drug Saf; 2017; 12(1):57-61. PubMed ID: 28067180
[TBL] [Abstract][Full Text] [Related]
20. [Hypnotics and anxiolytics: nominal daily delivery and development of their consumption at North University Hospital Center of Marseille (1991-1994)].
Jentile B; Amirat-Combralier V; Bues-Charbit M; Balansard G
J Pharm Belg; 1995; 50(6):489-93. PubMed ID: 8592279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
